AAAAAA

   
Results: 1-15 |
Results: 15
PROLONGED HYPERGASTRINEMIA DOES NOT INCREASE THE FREQUENCY OF COLONICNEOPLASIA IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME
Authors: ORBUCH M VENZON DJ LUBENSKY IA WEBER HC GIBRIL F JENSEN RT
Citation: M. Orbuch et al., PROLONGED HYPERGASTRINEMIA DOES NOT INCREASE THE FREQUENCY OF COLONICNEOPLASIA IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME, Digestive diseases and sciences, 41(3), 1996, pp. 604-613
HELICOBACTER-PYLORI INFECTION - A REVERSIBLE CAUSE OF HYPERGASTRINEMIA AND HYPERCHLORHYDRIA WHICH MAY MIMIC ZOLLINGER-ELLISON-SYNDROME
Authors: METZ DC WEBER HC ORBUCH M STRADER DB LUBENSKY IA JENSEN RT
Citation: Dc. Metz et al., HELICOBACTER-PYLORI INFECTION - A REVERSIBLE CAUSE OF HYPERGASTRINEMIA AND HYPERCHLORHYDRIA WHICH MAY MIMIC ZOLLINGER-ELLISON-SYNDROME, Digestive diseases and sciences, 40(1), 1995, pp. 153-159
DETERMINANTS OF METASTATIC RATE AND SURVIVAL IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME - A PROSPECTIVE LONG-TERM STUDY
Authors: WEBER HC VENZON DJ LIN JT FISHBEIN VA ORBUCH M STRADER DB GIBRIL F METZ DC FRAKER DL NORTON JA JENSEN RT
Citation: Hc. Weber et al., DETERMINANTS OF METASTATIC RATE AND SURVIVAL IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME - A PROSPECTIVE LONG-TERM STUDY, Gastroenterology, 108(6), 1995, pp. 1637-1649
ANATOMIC DISTRIBUTION OF PRIMARY GASTRINOMAS AND METASTASES IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME (ZES)
Authors: LUBENSKY IA FISHBEYN V METZ D ORBUCH M JENSEN RT
Citation: Ia. Lubensky et al., ANATOMIC DISTRIBUTION OF PRIMARY GASTRINOMAS AND METASTASES IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME (ZES), Laboratory investigation, 70(1), 1994, pp. 10000064-10000064
HELICOBACTER-PYLORI (HP) INFECTION AND ACID OUTPUT IN ZOLLINGER-ELLISON SYNDROME (ZES) - A PROSPECTIVE-STUDY
Authors: METZ DC WEBER C ORBUCH M STRADER DB GIBRIL F JENSEN RT
Citation: Dc. Metz et al., HELICOBACTER-PYLORI (HP) INFECTION AND ACID OUTPUT IN ZOLLINGER-ELLISON SYNDROME (ZES) - A PROSPECTIVE-STUDY, Gastroenterology, 106(4), 1994, pp. 10000138-10000138
PROLONGED, MARKED HYPERGASTRINEMIA DOES NOT INCREASE THE RATE OF COLONIC NEOPLASIA
Authors: ORBUCH M LUBENSKY IA WEBER HC STRADER DB GIBRIL F JENSEN RT
Citation: M. Orbuch et al., PROLONGED, MARKED HYPERGASTRINEMIA DOES NOT INCREASE THE RATE OF COLONIC NEOPLASIA, Gastroenterology, 106(4), 1994, pp. 10000152-10000152
DETERMINANTS OF METASTATIC RATE AND SURVIVAL IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME (ZES) - RESULTS OF A PROSPECTIVE LONG-TERM STUDY
Authors: WEBER HC VENZON DJ FISHBEIN VA ORBUCH M STRADER DB GIBRIL F JENSEN RT
Citation: Hc. Weber et al., DETERMINANTS OF METASTATIC RATE AND SURVIVAL IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME (ZES) - RESULTS OF A PROSPECTIVE LONG-TERM STUDY, Gastroenterology, 106(4), 1994, pp. 10000330-10000330
ZOLLINGER-ELLISON SYNDROME CAN BE THE INITIAL ENDOCRINE MANIFESTATIONIN PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA-TYPE-I
Authors: BENYA RV METZ DC VENZON DJ FISHBEYN VA STRADER DB ORBUCH M JENSEN RT
Citation: Rv. Benya et al., ZOLLINGER-ELLISON SYNDROME CAN BE THE INITIAL ENDOCRINE MANIFESTATIONIN PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA-TYPE-I, The American journal of medicine, 97(5), 1994, pp. 436-444
USE OF OMEPRAZOLE IN ZOLLINGER-ELLISON SYNDROME - A PROSPECTIVE 9-YEAR STUDY OF EFFICACY AND SAFETY
Authors: METZ DC STRADER DB ORBUCH M KOVIACK PD FEIGENBAUM KM JENSEN RT
Citation: Dc. Metz et al., USE OF OMEPRAZOLE IN ZOLLINGER-ELLISON SYNDROME - A PROSPECTIVE 9-YEAR STUDY OF EFFICACY AND SAFETY, Alimentary pharmacology & therapeutics, 7(6), 1993, pp. 597-610
PROSPECTIVE-STUDY OF THE NEED FOR LONG-TERM ANTISECRETORY THERAPY IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME FOLLOWING SUCCESSFUL CURATIVEGASTRINOMA RESECTION
Authors: METZ DC BENYA RV FISHBEYN VA PISEGNA JR ORBUCH M STRADER DB NORTON JA JENSEN RT
Citation: Dc. Metz et al., PROSPECTIVE-STUDY OF THE NEED FOR LONG-TERM ANTISECRETORY THERAPY IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME FOLLOWING SUCCESSFUL CURATIVEGASTRINOMA RESECTION, Alimentary pharmacology & therapeutics, 7(3), 1993, pp. 247-257
DISCOVERY OF A NOVEL CLASS OF NEUROMEDIN B-RECEPTOR ANTAGONISTS, SUBSTITUTED SOMATOSTATIN ANALOGS
Authors: ORBUCH M TAYLOR JE COY DH MROZINSKI JE MANTEY SA BATTEY JF MOREAU JP JENSEN RT
Citation: M. Orbuch et al., DISCOVERY OF A NOVEL CLASS OF NEUROMEDIN B-RECEPTOR ANTAGONISTS, SUBSTITUTED SOMATOSTATIN ANALOGS, Molecular pharmacology, 44(4), 1993, pp. 841-850
AN EVALUATION OF HUMAN RECOMBINANT ALPHA-INTERFERON IN PATIENTS WITH METASTATIC GASTRINOMA
Authors: PISEGNA JR SLIMAK GG DOPPMAN JL STRADER DB METZ DC BENYA RV ORBUCH M FISHBEYN VA FRAKER DL NORTON JA MATON PN JENSEN RT
Citation: Jr. Pisegna et al., AN EVALUATION OF HUMAN RECOMBINANT ALPHA-INTERFERON IN PATIENTS WITH METASTATIC GASTRINOMA, Gastroenterology, 105(4), 1993, pp. 1179-1183
GASTRINOMA CAN BE THE INITIAL PRESENTATION FOR PATIENTS WITH MULTIPLEENDOCRINE NEOPLASIA TYPE-I (MEN-I)
Authors: BENYA RV METZ DC FISHBEYN VA STRADER DB ORBUCH M JENSEN RT
Citation: Rv. Benya et al., GASTRINOMA CAN BE THE INITIAL PRESENTATION FOR PATIENTS WITH MULTIPLEENDOCRINE NEOPLASIA TYPE-I (MEN-I), Gastroenterology, 104(4), 1993, pp. 42-42
ENDOSCOPY, MANOMETRY AND HISTOPATHOLOGY OF THE ESOPHAGUS IN ZOLLINGER-ELLISON SYNDROME (ZES)
Authors: STRADER DB ORBUCH M FISHBEYN VA BENYA RV BENJAMIN SB LUBENSKY I JENSEN RT METZ DC
Citation: Db. Strader et al., ENDOSCOPY, MANOMETRY AND HISTOPATHOLOGY OF THE ESOPHAGUS IN ZOLLINGER-ELLISON SYNDROME (ZES), Gastroenterology, 104(4), 1993, pp. 199-199
PROSPECTIVE-STUDY OF THE BEST METHOD TO FIND DUODENAL GASTRINOMAS IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME (ZES)
Authors: FISHBEYN VA NORTON JA FRAKER DL BENYA RV STRADER DB ORBUCH M PISEGNA JR METZ DC JENSEN RT
Citation: Va. Fishbeyn et al., PROSPECTIVE-STUDY OF THE BEST METHOD TO FIND DUODENAL GASTRINOMAS IN PATIENTS WITH ZOLLINGER-ELLISON SYNDROME (ZES), Gastroenterology, 104(4), 1993, pp. 304-304
Risultati: 1-15 |